Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teh Seng Pharmaceutical Mfg CoROCO:7860 23 EBIT per Share is NT$4.26 as of Dec. 2025. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review. Among 812 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks worse than 123152.59% on this metric.
Teh Seng Pharmaceutical Mfg Co's EBIT per Share for the
six
months ended in Dec. 2025 was NT$2.72.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.26.
During the past 12 months, the average EBIT per Share Growth Rate of Teh Seng Pharmaceutical Mfg Co was -25.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Teh Seng Pharmaceutical Mfg Co's EBIT per Share or its related term are showing as below:
ROCO:7860's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.5 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Teh Seng Pharmaceutical Mfg Co EBIT per Share Related Terms
Teh Seng Pharmaceutical Mfg Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$4.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a EBIT per Share of NT$4.26 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 812 companies in the Drug Manufacturers industry.
Is Teh Seng Pharmaceutical Mfg Co's EBIT per Share too high?
Teh Seng Pharmaceutical Mfg Co's current EBIT per Share is NT$4.26. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 812 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's EBIT per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 812 companies for EBIT per Share. This places Teh Seng Pharmaceutical Mfg Co in the lower half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current EBIT per Share is NT$4.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current EBIT per Share of NT$4.26. The current EBIT per Share is NT$4.26. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current EBIT per Share is NT$4.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Business Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score
Get the complete analysis for ROCO:7860
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
